Ampol Ltd (ALD)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 39.20 |
|---|---|
| 52-week range | 27.58 – 45.49 |
| Return, 1 month / 3 months | −11.1% / +5.1% |
| Return, 1 year / 3 years | +33.8% / +44.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 28.5% |
| Worst drawdown (1 year) | -15.4% |
| Average daily value traded | 56.69M AUD |
| Dividend yield | 6.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ampol is an Australian fuel company that refines crude oil and supplies petrol, diesel and other petroleum products. It serves motorists through a network of service stations and convenience stores around Australia, and supplies fuel to commercial and industrial customers. The company also operates a refinery and fuel import and distribution facilities, and it is based in Australia, where its retail brand is familiar to drivers.
On this site Ampol Ltd appears as a stock on the Australian Securities Exchange (Australia), code ALD, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ampol Ltd (ALD) trades on the Australian Securities Exchange in Australia. It last closed at AUD 39.20 on 23 October 2026.
Its price-based Market X-Ray is 88 out of 100 (a strong price profile), ranking 6 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.8% and over the last three months it rose 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.1% | ||
| From 52-week high | -12.6% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.1% | ||
| 6-month return | 22.3% | ||
| 12-month return, skipping the last month | 50.4% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.4% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 56.69M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −8.9% |
|---|---|
| 1 month | −11.1% |
| 3 months | +5.1% |
| 6 months | +22.3% |
| 1 year | +33.8% |
| 3 years | +44.4% |
| 5 years | +65.0% |
Signals
| 50-day / 200-day average | 41.89 / 34.36 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Sep 2026 | AUD 1.8500 |
| 6 Mar 2026 | AUD 0.6000 |
| 29 Aug 2025 | AUD 0.4000 |
| 7 Mar 2025 | AUD 0.0500 |
| 30 Aug 2024 | AUD 0.6000 |
| 1 Mar 2024 | AUD 1.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.